Patent application number | Description | Published |
20130233636 | GAS GENERATING COMPOSITION AND USE THEREOF IN PEDESTRIAN PROTECTION DEVICES - The invention relates to gas generating compositions for use in safety devices for vehicles. In particular, the invention relates to said compositions based on guanidine nitrate used in pedestrian protection devices. The composition substantially comprises 75 to 98% by weight of guanidine nitrate as fuel and 2 to 25% by weight of a burn accelerator selected from the group of the transition metal compounds, the metal nitrates, metal chlorates, metal perchlorates, ammonium perchlorate and mixtures thereof, wherein the transition metal compounds are selected from the compounds of the transition metals Ti, Cr, Mn, Fe, Cu, Zn, Zr and Mo and wherein the gas generating composition exhibits a burn rate of from 3 to 17 mm/s at 20 MPa. | 09-12-2013 |
20130248062 | GAS GENERATING COMPOSITION - The present invention provides a gas generating composition, especially for use in safety devices for vehicles, comprising a) 40 to 60% by weight of a fuel consisting of one or more components selected from the group of guanidine compounds; b) 40 to 60% by weight of basic copper nitrate; c) 0 to 8% by weight of at least one transition metal oxide; d) 1 to 5% by weight of at least one stabilizer component and e) 0 to 5% by weight of further additives, each related to the total weight of the components a) through e); the stabilizer component at room temperature having a solubility in water of not more than 1 g/100 ml and the solubility in water at T=90° C. amounting to at least seven times the solubility at room temperature. | 09-26-2013 |
20150307410 | GAS GENERATING COMPOSITION AND USE THEREOF IN PEDESTRIAN PROTECTION DEVICES - The invention relates to gas generating compositions for use in safety devices for vehicles. In particular, the invention relates to said compositions based on guanidine nitrate used in pedestrian protection devices. The composition substantially comprises 75 to 98% by weight of guanidine nitrate as fuel and 2 to 25% by weight of a burn accelerator selected from the group of the transition metal compounds, the metal nitrates, metal chlorates, metal perchlorates, ammonium perchlorate and mixtures thereof, wherein the transition metal compounds are selected from the compounds of the transition metals Ti, Cr, Mn, Fe, Cu, Zn, Zr and Mo and wherein the gas generating composition exhibits a burn rate of from 3 to 17 mm/s at 20 MPa. | 10-29-2015 |
Patent application number | Description | Published |
20090176223 | Compositions, Kits, and Methods for the Diagnosis, Prognosis, and Monitoring of Immune Disorders Using Galectin-1 - The present invention is based, in part, on the discovery that galectin-1 (Gal1) plays a role in immune disorders, including Hodgkin lymphoma, anaplastic large cell lymphoma, or MLL | 07-09-2009 |
20090191182 | Compositions, Kits, and Methods for the Modulation of Immune Responses Using Galectin-1 - The present invention is based, in part, on the discovery that galectin-1 (Gal1) plays a role in immune disorders, including Hodgkin lymphoma. Accordingly, the invention relates to compositions, kits, and methods for detecting, characterizing, modulating, preventing, and treating immune disorders, e.g., Hodgkin lymphoma. | 07-30-2009 |
Patent application number | Description | Published |
20130011409 | Compositions, Kits, and Methods for the Diagnosis, Prognosis, Monitoring, Treatment and Modulation of Post-Transplant Lymphoproliferative Disorders and Hypoxia Associated Angiogenesis Disorders Using Galectin-1 - The present invention is based, in part, on the discovery that galectin-1 (Gal1) plays a role in viral-associated PTLD, e.g., EBV-associated PTLD and hypoxia associated angiogenesis disorders. Accordingly, the invention relates to compositions, kits, and methods for diagnosing, prognosing, monitoring, treating and modulating viral-associated PTLD, e.g., EBV-associated PTLD and hypoxia associated angiogenesis disorders. | 01-10-2013 |
20150191536 | Compositions, Kits, and Methods for the Diagnosis, Prognosis, Monitoring, Treatment and Modulation of Post-Transplant Lymphoproliferative Disorders and Hypoxia Associated Angiogenesis Disorders Using Galectin-1 - The present invention is based, in part, on the discovery that galectin-1 (Gal1) plays a role in viral-associated PTLD, e.g., EBV-associated PTLD and hypoxia associated angiogenesis disorders. Accordingly, the invention relates to compositions, kits, and method for diagnosing, prognosing, monitoring, treating and modulating viral-associated PTLD, e.g., EBV-associated PTLD and hypoxia associated angiogenesis disorders. | 07-09-2015 |